Trial Profile

A phase III randomized study of hypofractionated 3D-CRT [3-dimensional conformal radiation therapy]/MRT [modulated radiation therapy] versus conventionally fractionated 3D-CRT/MRT in patients with favorable-risk prostate cancer.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Feb 2020 Biomarkers information updated
03 Aug 2012 Planned End Date changed from 1 May 2011 to 1 Feb 2021 as reported by ClinicalTrials.gov.
22 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com